Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulin-like growth factor-I in chronic heart failure

Basic Research in Cardiology

Volumn 98, Issue 4, 2003, Pages 267-274

  Schulze, P Christian ^a,b,c   Gielen, Stephan ^b   Adams, Volker ^b   Linke, Axel ^b   Möbius Winkler, Sven ^b   Erbs, Sandra ^b   Kratzsch, Jürgen ^b   Hambrecht, Rainer ^b   Schuler, Gerhard ^b  

^a Partners Research Facility   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic heart failure; Cytokines; Growth factors; Skeletal muscle

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CACHEXIA; CATABOLISM; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORRELATION ANALYSIS; DISEASE MODEL; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MICROSCOPY; MORPHOLOGY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE LEVEL; MUSCLE METABOLISM; NONHUMAN; PATHOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

EID: 0038637236     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-003-0411-1     Document Type: Article

References (42)

1. Adams V, Jiang H, Yu J, Möbius-Winkler S, Fiehn E, Linke A, Weigl C, Schuler G, Hambrecht R (1999) Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 33: 959-965
2. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJS (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96: 526-534
3. Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJS (2001) Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone. J Am Coll Cardiol 38: 443-452
4. Bayat S, Swaney JS, Ander AN, Dalton N, Kennedy BP, Hammond HK, Roth DM (2002) Progressive heart failure after myocardial infarction in mice. Basic Res Cardiol 97: 206-213
5. Bishop A, Travers KE, Grossman J, Johnson H, Perreault C, Woolf JH, Cittadini A, Gonzalez-Serratos H, Morgan JP (1998) Alterations in heart failure of cyclic AMP-dependent inotropic and lusitropic properties of cardiac and skeletal muscle. Ann N Y Acad Sci 853: 209-219
6. Charter Y, Grimble RF (1989) Effect of recombinant human tumor necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats. Biochem J 258: 493-497
7. Clark A, Coats A (1994) Mechanisms of exercise intolerance in cardiac failure: Abnormalities of skeletal muscle and pulmonary function. Curr Opin Cardiol 9: 305-314
8. Douglas PS, Tallant B (1991) Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. J Am Coll Cardiol 17: 536
9. Douglas RG, Gluckman PD, Breier BH, McCall JL, Parry B, Shaw JH (1991) Effects of recombinant IGF-I on protein and glucose metabolism in rTNF-infused lambs. Am J Physiol 261: E606-E612
10. Drexler H, Riede U, Münzel T, König H, Funke E, Just H (1992) Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759
11. Fan J, Char D, Bagby GJ, Gelato MC, Lang CH (1995) Regulation of insulin-like growth factor-1 (IGH-1) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 269 (5 Pt 2): R1204-R1212
12. Goldspink DF, Cox VM, Smith SK, Eaves LA, Osbaldeston NJ, Lee DM, Mantle D (1995) Muscle growth in response to mechanical stimuli. Am J Physiol 268: E288-297
13. Habib FM, Springall DR, Davie GJ, Oakley CM, Yacoub MH, Polak JM (1996) Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347: 1151-1155
14. Hambrecht R, Adams V, Gielen S, Linke A, Möbius-Winkler S, Yu J, Niebauer J, Jiang H, Fiehn E, Schuler G (1999) Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 33: 174-179
15. Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, Adams V, Riede U, Schuler G (1997) Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 29: 1067-1073
16. Hambrecht R, Schulze PC, Gielen S, Linke A, Mobius-Winkler S, Yu J, Kratzsch JJ, Baldauf G, Busse MW, Schubert A, Adams V, Schuler G (2002) Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol 39: 1175-1181
17. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski P, Poole-Wilson PA, Coats AJS (1997) Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30: 1758-1764
18. Jobin C, Sartor RB (2000) The Ikb/NFkB system: A key determinant of mucosal inflammation and protection. Am J Phys 278: C451-C462
19. Klahr S, Morrissey JJ (2000) The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 57: S7.
20. Kratzsch J, Blum WF, Schenker E, Keller E, Jahries G, Haustein B, Ventz M, Rotzsch W (1993) Measurements of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: Experience with a new competitive enzyme immunoassay. Exp Clin Endocrinol 101: 144-149
21. Kristen AV, Just A, Haass M, Seller H (2002) Central hypercapnic chemoreflex modulation of renal sympathetic nerve activity in experimental heart failure. Basic Res Cardiol 97: 177-186
22. Lang CH, Fan J, Wojnar MM, Vary TC, Cooney R (1998) Role of central IL-1 in regulating peripheral IGF-I during endotoxemia and sepsis. Am J Physiol 274: R962
23. Levine B, Kalman J, Mayer L, Fillit HM, Packer MP (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323: 236-241
24. Loughna PT, Mason P, Bates PC (2000) Regulation of insulin-like growth factor 1 gene expression in skeletal muscle. Symp Soc Exp Biol 46: 319-330
25. Mabley JG, Belin V, John N, Green IC (1997) Insulin-like growth factor I reverses interleukin-1beta inhibition of insulin secretion, induction of nitric oxide synthase and cytokine-mediated apoptosis in rat islets of Langerhans. FEBS Lett 417: 235-238
26. Mancini D, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85: 1364-1373
27. Minotti JR, Christoph I, Oka R, Weiner MW, Wells I, Massie BM (1991) Impaired skeletal muscle function in patients with congestive heart failure: Relationship to systemic exercise performance. J Clin Invest 88: 2077-2082
28. Ng EH, Rock CS, Lazarus DD, Stiaino-Coico L, Moldawer LL, Lowry SF (1992) Insulin-like growth factor I preserves host lean tissue mass in cancer cachexia. Am J Physiol 262: R426-R431
29. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, Anker SD (1998) Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 32: 393-397
30. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson P, Coats A, Anker S (1999) Endotoxin and immune activation in chronic heart failure: A prospective cohort study. The Lancet 353: 1838-1842
31. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E (1991) Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 260: H1406-H1414
32. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P (1994) Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 121: 860-862
33. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxter LM, Heasley LE, Reusch JE (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766
34. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM (1996) Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 79: 128-136
35. Sullivan MJ, Green HJ, Cobb FR (1990) Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81: 518-527
36. Swan JM, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJS (1997) Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure. J Am Coll Cardiol 30: 527-532
37. Thissen JP, Verniers J (2000) Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078-1084
38. Thomas MJ, Umayahara Y, Shu H, Centrella M, Rotwein P, McCarthy TL (1996) Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J Biol Chem 271: 21835-21835
39. Torti SV, Akimoto H, Lin K, Billingham ME, Torti FM (1998) Selective inhibition of muscle gene expression by oxidative stress in cardiac cells. J Mol Cell Cardiol 30: 1173-1180
40. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, Nakamura K, Ichikawa K, Utsumi H, Takeshita A (2001) Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 104: 134-136
41. Valdez H, Lederman MM (1997) Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev, 187-228
42. Yi-Ping L, Reid MB (2000) NFkB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Phys 279: R1165-R1170